Stock 300119 TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Tianjin Ringpu Bio-Technology Co.,Ltd.

Equities

300119

CNE100000TV1

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 30/04/2024 am IST 		5-day change 1st Jan Change
16.39 CNY +4.20% Intraday chart for Tianjin Ringpu Bio-Technology Co.,Ltd. +2.76% -.--%
25/04 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
30/03 Tianjin Ringpu Bio-Technology Co.,Ltd. agreed to acquire Baoding Shoujun Technology Co., Ltd. from Yao Lili, Zhang Xiaoqin and Tianjin Ruichuang Biotechnology Partnership (Limited Partnership) for CNY 230 million. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Proposes Final Dividend for the Year 2023
CI
Tianjin Ringpu Bio-Technology Co.,Ltd. agreed to acquire Baoding Shoujun Technology Co., Ltd. from Yao Lili, Zhang Xiaoqin and Tianjin Ruichuang Biotechnology Partnership (Limited Partnership) for CNY 230 million.
CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Tranche Update on Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback Plan announced on October 27, 2023.
CI
Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback announced on October 27, 2023, has closed with 3,689,608 shares, representing 0.8% for CNY 59.99 million.
CI
Tranche Update on Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback Plan announced on October 27, 2023.
CI
Tianjin Ringpu Bio-Technology Co.,Ltd. announces an Equity Buyback for CNY 80 million worth of its shares.
CI
Tianjin Ringpu Bio-Technology Co.,Ltd. authorizes a Buyback Plan.
CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Luzhu Biotechnology Ties Up With Tianjin Ringpu to Develop Pet Vaccines, Drugs
MT
Beijing Luzhu Biotechnology Co., Ltd. and Tianjin Ringpu Bio-Technology Co., Ltd. Announces Strategic Cooperation Framework Agreement
CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date: 08 June 2023
CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Approves Cash Dividend for 2022
CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Proposes Final Cash Dividend for the Year 2022
CI
Tianjin Ringpu Bio-Technology Co.,Ltd. signed an agreement to acquire 15% stake in Fujian Sunvet Biotechnology Co., Ltd. from Guo Haiyan and 16 natural person shareholders for CNY 63 million.
CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Announces Executive Appointments
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 300119 Stock
  4. News Tianjin Ringpu Bio-Technology Co.,Ltd.